Viewing Posts from August, 2021

  • glaucoma sleep 600

    Study Shows Link Between Poor Sleep and Glaucoma

    A recent cross-sectional study including over 6,700 subjects investigated the relationship between glaucoma and sleep. Participants responded to National Health and Nutrition Examination Survey, responding to questions about sleep duration,...

  • eye health 600

    Study Suggests Exercise Helps Prevent Eye Disease

    A study at the University of Virginia School of Medicine suggests that regular exercise can prevent or slow the development of macular degeneration.

  • Study Reports on Safety, Efficacy of Bevacizumab Biosimilar Stivant®

    A research study including 351 patients (385 eyes) at Farabi Eye Hospital, Tehran, Iran, September 2018 to February 2019, studied the use of the intravitreal injection of the bevacizumab biosimilar Stivant®.

  • Study Indicates Bevacizumab Biosimilar Safe and Effective For Retinal Neovascular Conditions

    A 2017 study at various eye care centers in India was conducted to evaluate the efficacy and safety profile of intravitreal injection of a bevacizumab biosimilar for different retinal neovascular conditions.

  • Haiti eye mission Kristin 600X400

    Haiti Mission Strives to Prevent Blindness

    Here at Edge Pharma, we were very pleased to learn of the success of the most recent Haiti Eye Mission trip to Pignon, Haiti.

  • biosimilars drugs 600X500

    Biosimilars in the News

    Biosimilars are an important topic in U.S. health care news in the summer of 2021. July 9, President Joe Biden signed an executive order to promote competition in the American economy.

  • Eating Right For Sight 600px

    Eating Right For Sight

    The American Academy of Ophthalmology states “foods rich in vitamins C and E, zinc, lutein, zeaxanthin, and omega-3 fatty acids are linked to lower risk for age-related macular degeneration (AMD),...

  • Endophthalmitis prevention 600X400

    Povidone-Iodine and Prevention of Endophthalmitis

    New treatments for eye diseases, such as diabetic retinopathy, retinal vein occlusions, and choroidal neovascularization have in recent years led to an increase in intravitreal injections.